Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 9,999 shares at $80.03 ($806K) on 2026-10-12, disclosed to the SEC on 2026-10-13.
Scheduled sale ($806k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.03 | 5,741 | $459K | 57.0% |
| 2 | $80.76 | 2,100 | $170K | 21.0% |
| 3 | $81.86 | 1,958 | $160K | 19.9% |
| 4 | $82.83 | 200 | $17K | 2.1% |
| Total | $80.60 avg | 9,999 | $806K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |
| ORKA | SELL | 2026-06-22 | $128K | — | Filing → |